Skip to main content

Table 3 Characteristics of respondents (n=80) stratified by site

From: Prioritizing strategies for comprehensive liver cancer control in Asia: a conjoint analysis

  All China Japan South Korea Taiwan p-value
Primary Role, %
Clinicians 60.0 15.0 15.0 15.0 15.0 0.196
Hepatologist 18.8 2.5 5.0 7.5 3.8  
Oncologist 21.3 10.0 2.5 1.3 7.5  
Radiologist 3.8 1.3 1.3 1.3 0.0  
Surgeon 12.5 0.0 8.3 4.2 0.0  
Other 3.8 0.4 1.1 1.1 1.1  
Policy makers 25.0 6.3 6.3 6.3 6.3 0.167
Governmental 18.8 5.0 6.3 5.0 2.5  
Non-Governmental 6.3 1.3 0.0 1.3 3.8  
Advocates 15.0 3.8 3.8 3.8 3.8 0.518
Disease advocacy 5.0 0.0 1.3 1.3 2.5  
Media/Spokesperson 3.8 1.3 1.3 0.0 1.3  
Patient advocacy 6.3 2.5 1.3 2.5 0.0  
Area of Involvement, %       0.002**
Hepatitis 26.3 5.0 11.3 3.8 6.3  
HCC 57.5 17.5 13.7 16.3 10.0  
Metastatic liver cancer 10.0 2.5 0.0 0.0 7.5  
Transplantation 6.3 0.0 0.0 5.0 1.3  
Level of Involvement, %       0.029*
International 15.0 3.8 3.8 5.0 2.5  
Local/municipality 6.3 5.0 0.0 1.3 0.0  
National 56.3 13.7 11.3 17.5 13.7  
Regional/provincial 22.5 2.5 10.0 1.3 8.8  
  1. *p<0.05, **p<0.01.